The emergence of “designer drugs” has become a major concern for the addiction and behavioral healthcare communities. These “designer drugs,” better classified as synthetic cannabinoids, synthetic stimulants, hallucinogens, psychedelic-stimulants, and older drug categories trying to make a come-back are making treatment and education very difficult for clinicians and the families of those affected.
In this webinar Lisa Marzilli, PharmD, will discuss current trends and issues surrounding these new and emerging products. Lisa will also identify how efforts to stay current remain a challenge both scientifically and legally. Finally, she will discuss how geography dictates the “flavor-of-the-week” and what substances to be on the lookout for in your area of practice.
- Identify the key characteristics and effects of synthetic drugs, most notably synthetic cannabinoids, synthetic cathinones and synthetic stimulants
- Assess strategies for communicating the dangers involved with synthetic drug use
- Describe the current information on the availability and patterns of synthetic drug use in the United States
The Association for the Addiction Professionals - NAADAC
This course has been approved by Vendome Group, LLC, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider # 993121, Vendome Group LLC is responsible for all aspects of their programming.
NAADAC, the Association for Addiction Professionals, represents the professional interests of more than 85,000 addiction counselors, educators and other addiction-focused health care professionals in the United States, Canada and abroad. NAADAC’s members are addiction counselors, educators and other addiction-focused health care professionals, who specialize in addiction prevention, treatment, recovery support and education. An important part of the healthcare continuum, NAADAC members and its 47 state affiliates work to create healthier individuals, families and communities through prevention, intervention, quality treatment and recovery support.